Table 2 Patterns of failure and survival in cervical cancers with pelvic, para-aortic and/or supraclavicular lymph node metastasis treated with PET-guided extended-field dose-escalating chemo-IMRT/3D-brachytherapy
Outcomes | Pelvic LAP | Paraaortic LAP | SC LAP | Total (%) |
|---|---|---|---|---|
Dead/Total | 5/26 | 12/31 | 6/15 | 23/72 (31.9) |
In-field failure-only (cervix, lymph nodes) | 2 | 5 | 1 | 8 (11.1) |
Out-of-field failure-only (lymph node, bone and/or visceral metastases) | 5 | 8 | 5 | 18 (25.0) |
Both failures | 1 | 2 | 0 | 3 (4.2) |
Survival | ||||
1-year DFS (%) | 91.7 | 89.9 | 75.0 | – |
3-year DFS (%) | 78.5 | 55.8 | 75.0 | – |
5-year DFS (%) | 78.5 | 41.8 | 50.0 | – |